There has been a call for comprehensive cancer care that gives greater consideration to changing lifestyle risk factors such as smoking to improve prognosis and long-term health. Cancer diagnosis, treatment, and survivorship offer challenges and opportunities (“teachable moments”) to promote smoking cessation.
Methods
This review provides a rationale for the importance of smoking cessation programs in the cancer context, highlights practice guidelines for the delivery of these interventions, summarizes the challenges to smoking cessation unique to cancer patients, and recommends approaches to capitalize on the cancer context to promote smoking cessation.
Results
Barriers to smoking cessation by patients with cancer include heavy nicotine dependence, urgency of cessation, fatalistic attitudes about cessation benefits, cancer-related psychological distress, treatment factors, and the presence of smokers in the social network. Opportunities to promote cessation include the transition from inpatient to outpatient care, involvement in cancer patient care by family members who smoke, and distribution of clinical feedback (eg, test results).
Conclusions
Teachable moments in the cancer context are not being fully utilized to promote smoking cessation. Evidence-based guidelines can assist cancer care teams in promoting cessation.
References
1.
American Cancer Society.Cancer Facts & Figures, 2003.Atlanta, Ga: American Cancer Society, Inc; 2003: 1–48.
2.
KoC., ChaudhryS.. The need for a multidisciplinary approach to cancer care.J Surg Res.2002; 105: 53–57.
3.
KuperH., BoffettaP., AdamiH.O.. Tobacco use and cancer causation: association by tumour type.J Intern Med.2002; 252: 206–224.
4.
KawaharaM., UshijimaS., KamimoriT.. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation.Br J Cancer.1998; 78: 409–412.
5.
TuckerM.A., MurrayN., ShawE.G.. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre.J Natl Cancer Inst.1997; 89: 1782–1788.
6.
RussoA., CrosignaniP., BerrinoF.. Tobacco smoking, alcohol drinking and dietary factors as determinants of new primaries among male laryngeal cancer patients: a case-cohort study.Tumori.1996; 82: 519–525.
7.
SilvermanS.Jr, GorskyM., GreenspanD.. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers.J Am Dent Assoc.1983; 106: 33–35.
8.
KhuriF.R., KimE.S., LeeJ.J.. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.Cancer Epidemiol Biomarkers Prev.2001; 10: 823–829.
9.
HongW.K., LippmanS.M., ItriL.M.. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.N Engl J Med.1990; 323: 795–801.
10.
van ZandwijkN., DalesioO., PastorinoU.. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.J Natl Cancer Inst.2000; 92: 977–986.
11.
DuffyS.A., TerrellJ.E., ValensteinM.. Effects of smoking, alcohol and depression on the quality of life of head and neck cancer patients.Gen Hosp Psychiatry.2002; 24: 140–147.
12.
AsaphJ.W., HandyJ.R.Jr., GrunkemeierG.L.. Median sternotomy versus thoracotomy to resect primary lung cancer: analysis of 815 cases.Ann Thorac Surg.2000; 70: 373–379.
13.
FujisawaT., IizasaT., SaitohY.. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas.J Clin Oncol.1999; 17: 2086–2091.
14.
BrowmanG.P., WongG., HodsonI.. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer.N Engl J Med.1993; 328: 159–163.
15.
NeugutI., MurrayT., SantosJ.. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers.Cancer.1994; 73: 1615–1620.
16.
ProchazkaM., GranathF., EkbomA.. Lung cancer risks in women with previous breast cancer.Eur J Cancer.2002; 38: 1520–1525.
17.
MurinS., InciardiJ.. Cigarette smoking and the risk of pulmonary metastasis from breast cancer.Chest.2001; 119: 1635–1640.
18.
van LeeuwenF.E., KlokmanW.J., StovallM.. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.J Natl Cancer Inst.1995; 87: 1530–1537.
19.
ShawH.M., MiltonG.W.. Smoking and the development of metastases from malignant melanoma.Int J Cancer.1981; 28: 153–156.
20.
DreslerC.M., BaileyM., RoperC.R.. Smoking cessation and lung cancer resection.Chest.1996; 110: 1199–1202.
21.
WarnerM.A., OffordK.P., WarnerM.E.. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients.Mayo Clin Proc.1989; 64: 609–616.
22.
RuggT., SaundersM.I., DischeS.. Smoking and mucosal reactions to radiotherapy.Br J Radiol.1990; 63: 554–556.
23.
StewartJ.R., FajardoL.F., GilletteS.M.. Radiation injury to the heart.Int J Radiat Oncol Biol Phys.1995; 31: 1205–1211.
24.
OstroffJ.S., JacobsenP.B., MoadelA.B.. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer.Cancer.1995; 75: 569–576.
25.
Centers for Disease Control.Cigarette smoking among adults: United States, 2000.MMWR.2002; 51: 642–645.
26.
OstroffJ., GarlandJ., MoadelA.. Cigarette smoking patterns in patients after treatment of bladder cancer.J Cancer Educ.2000; 15: 86–90.
27.
Demark-WahnefriedW., PetersonB., McBrideC.. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas.Cancer.2000; 88: 674–684.
28.
GritzE.R., SchachererC., KoehlyL.. Smoking withdrawal and relapse in head and neck cancer patients.Head Neck.1999; 21: 420–427.
29.
GritzE.R., CarrC.R., RapkinD.A.. A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics.Cancer Epidemiol Biomarkers Prev.1991; 1: 67–73.
30.
SchillingA., ConawayM.R., WingateP.J.. Recruiting cancer patients to participate in motivating their relatives to quit smoking: a cancer control study of the Cancer and Leukemia Group B (CALGB 9072).Cancer.1997; 79: 152–160.
31.
OstroffJ.S., BucksheeN., MancusoC.A.. Smoking cessation following CT screening for early detection of lung cancer.Prev Med.2001; 33: 613–621.
32.
EmmonsK., LiF.P., WhittonJ.. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study.J Clin Oncol.2002; 20: 1608–1616.
33.
GreenlundK.J., JohnsonC.C., WebberL.S.. Cigarette smoking attitudes and first use among third- through sixth-grade students: the Bogalusa Heart Study.Am J Public Health.1997; 87: 1345–1348.
34.
KendlerK.S., NealeM.C., SullivanP.. A population-based twin study in women of smoking initiation and nicotine dependence.Psychol Med.1999; 29: 299–308.
35.
VentersM.H., SolbergL.I., KottkeT.E.. Smoking patterns among social contacts of smokers, ex-smokers, and never smokers: the Doctors Helping Smokers Study.Prev Med.1987; 16: 626–635.
36.
FranksM.M., PientaA.M., WrayL.A.. It takes two: marriage and smoking cessation in the middle years.J Aging Health.2002; 14: 336–354.
37.
McBrideC., PollakK.I., GarstJ.. Emotional distress and motivation for smoking cessation among relatives of lung cancer patients. Presented at the 2002 National Conference on Tobacco or Health; November 20, 2002; San Francisco, Calif.
38.
FioreM.C., BaileyW.C., CohenS.J.. Treating Tobacco Use and Dependence: Clinical Practice Guideline.Washington, DC: US Dept of Health and Human Services; June 2000. Public Health Service publication no. 000032. Available at http://www.surgeongeneral.gov/tobacco/. Accessed March 27, 2003.
39.
MarlattG.A., GordonJ.R., eds. Maintenance Strategies in the Treatment of Addictive Behaviors.New York, NY: Guilford Press; 1985.
40.
WhitlockE.P., OrleansC.T., PenderN.. Evaluating primary care behavioral counseling interventions: an evidence-based approach.Am J Prev Med.2002; 22: 267–284.
41.
SongF., RafteryJ., AveyardP.. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.Med Decis Making.2002; 22(5 suppl): S26–S37.
SchnollR.A., MalstromM., JamesC.. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer.Patient Educ Couns.2002; 46: 137–145.
50.
GritzE.R., CarrC.R., RapkinD.. Predictors of long-term smoking cessation in head and neck cancer patients.Cancer Epidemiol Biomarkers Prev.1993; 2: 261–270.
51.
Oncology Nursing Society.Tobacco prevention and cessation in oncology nursing practice, education and research.Oncol Nurs Forum.1995; 22: 256–257.
52.
McBrideC.M., EmmonsK.M., LipkusI.M.. Understanding the potential of teachable moments for motivating smoking cessation.Health Educ Res.2003; 18: 156–170.
53.
RollnickS., ButlerC.C., StottN.. Helping smokers make decisions: the enhancement of brief intervention for general medical practice.Patient Educ Couns.1997; 31: 191–203.
54.
LewisF.M.. The impact of cancer on the family: a critical analysis of the research literature.Patient Edu Counsel.1986: 269–289.
55.
OstroffJ., BurkhalterJ., RossS.. Changes in tobacco use patterns among family members of cancer patients.Ann Behav Med.2002; 24: S224.
56.
SarnaL.. Smoking behaviors of women after diagnosis with lung cancer.Image J Nurs Sch.1995; 27: 35–41.
